Drug intelligence / Profile preview

beta-D-glucan

Development stage
Phase 2
Modality
Microbiome Therapeutics
Administration
Oral, Topical, Intravenous (as A Diagnostic Test In Serum)
01

Overview

Beta-D-glucan is a polysaccharide composed of D-glucose molecules linked mainly by β-1,3 and β-1,6 glycosidic bonds. It is naturally found in the cell walls of fungi, certain bacteria, algae, and grains like oats and barley. In a clinical context, beta-D-glucan is most notably used as a biomarker for diagnosing invasive fungal infections (IFIs) due to its abundance in fungal cell walls; its detection in serum provides an early, non-culture-based indication of IFI, especially involving Candida, Aspergillus, Pneumocystis jirovecii, and Fusarium. As a supplement, beta-D-glucan is investigated for cardiovascular benefits (cholesterol lowering), blood sugar regulation, digestive health, immune modulation, wound healing, and as an adjunct in cancer immunotherapy, attributed to its effects on innate and adaptive immunity, including stimulation of macrophages, dendritic cells, and cytokine secretion. Sources and effects vary by origin and molecular structure[1][3][4][7][8][10].

Brand names
Fungitell
Other names
1,3-beta-D-glucanBDGbeta-glucanβ-glucan(1→3)-β-D-glucan(1,3)-β-D-glucan
02

Targets

αMβ2 (Integrin αMβ2)CLEC7A (Dectin-1)LacCer (Lactosylceramide)CD36 (CD36 antigen)

Beyond the preview

Go deeper on beta-D-glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-D-glucan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call